Prostate Cancer Clinical Trials

Showing 1401-1420 of 2,150 trials

Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00003238

RATIONALE: Drugs used in chemotherapy use different way to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol in treating patients with metastatic prostate cancer that has not responded to hormone therapy with androgens.

Prostate Cancer

University of Wisconsin, MadisonStarted Feb 1998

Freeport, Illinois, United States • Green Bay, Wisconsin, United States • Janesville, Wisconsin, United States +5 more locations

TERMINATEDPhase 2

Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer

NCT00582582

The purpose of this research study is to find out the toxicities of doxercalciferol given in combination with docetaxel (Taxotere®), as well as to see how well this combination works in the treatment of prostate cancer.

Prostate Cancer

University of Wisconsin, Madison70 participantsStarted Apr 2002

Madison, Wisconsin, United States

COMPLETEDPhase 2

Doxercalciferol Before Surgery in Treating Localized Prostate Cancer

NCT00022412

RATIONALE: Doxercalciferol may be an effective way to treat localized prostate cancer before surgery. PURPOSE: Randomized phase II trial to study the effectiveness of giving doxercalciferol before surgery in treating patients who have localized prostate cancer.

Prostate Cancer

University of Wisconsin, Madison60 participantsStarted Aug 2001

Iowa City, Iowa, United States • Rochester, New York, United States • Madison, Wisconsin, United States +3 more locations

Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer

Doxercalciferol Before Surgery in Treating Localized Prostate Cancer

Related Searches

CamPROBE: Developing a Safer and Simple Device for Local Anaesthetic Transperineal Prostate Biopsies

177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer

Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate.

Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy

Cardiovascular Events in GnRH Agonist vs. Antagonist

Personalized Mini-PDX for Metastatic CRPC

Phase I/II Hypofractionated Radiotherapy for Prostate Cancer

Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a

Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)

Modifications to Radical Prostatectomy: Feasibility Study

ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer

Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

Therapeutics in Active Prostate Cancer Surveillance

Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer

Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib

Survivorship Care Plans in a Community Oncology Practice

The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer Diagnosis